Shanghai, April 1, 2026 – At the “CGT Awards” 2026 Asia-Pacific Cell & Gene Therapy Industry Star Awards Ceremony hosted by TaaSi Labs, Concora Group stood out among numerous nominees and won the “Best Biopharmaceutical Industrial Park of the Year” award, in recognition of its outstanding performance in life science infrastructure development and innovative ecosystem services.
As one of the most influential industry events in the Asian CGT sector, this year’s summit marked a decade of progress, bringing together leading scientists, clinical researchers, business leaders, and policy experts to explore cutting-edge trends and future pathways in cell and gene therapy.
About Concora: An Infrastructure Innovator Deeply Rooted in the Life Science Industry
Concora focuses on the investment, development, and operation of life science industrial infrastructure. Driven by the dual-engine model of “specialized space + innovation services,” Concora has built a complete industrial ecosystem spanning from early-stage incubation to large-scale production. Its two flagship parks – Concora Med Valley and Concora Place – serve the full lifecycle needs of biopharmaceutical companies through differentiated positioning.
Concora Valley – 118 Furonghua Road
Concora Valley, located in the core area of the Shanghai International Medical Zone, is a specialized R&D and industrial base dedicated to the biopharmaceutical value chain, covering the entire process from benchtop R&D, pilot-scale testing, to commercial production. Leveraging deep synergies with the “four medicals” – Medicine, Pharmaceuticals, Hospitals, and Healthcare – the park has fostered a significant biopharmaceutical cluster, creating a complete life science industrial ecosystem.
Concora Place – 2966 Jinke Road
Concora Place, situated in the core area of the Shanghai International Medical Zone, enjoys excellent transportation links and fully integrated commercial, residential, and living amenities. With high-quality infrastructure and one-stop operational services, the park offers “plug-and-play” shared laboratories and flexible office spaces, enabling innovative teams to launch quickly and grow efficiently.
EverLab Shared Laboratory Platform – 2966 Jinke Road
EverLab Shared Laboratory Platform within the park focuses on early-stage biopharmaceutical R&D and cutting-edge incubation projects. It provides ready-to-use lab spaces, standardized lab operation services, full-process value-added support, and an international academic exchange ecosystem. Facilities include molecular/analytical labs, P1/P2 cell culture labs, and well-equipped office and meeting spaces, offering crucial support for early-stage biopharmaceutical development and advanced incubation initiatives.
